Novartis AGcompleted the acquisition of Regulus Therapeutics Inc..
Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher
Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million
Novartis to buy Regulus Therapeutics for up to $1.7 billion
Regulus Therapeutics Stock Shoots Higher After Positive Results From Investigational Drug For Rare Type Of Kidney Disease